KVP Capital Advisors »

Cabaletta Bio shares owned by KVP Capital Advisors

Quarter-by-quarter ownership of Cabaletta Bio (CABA) shares owned by KVP Capital Advisors from 13F filings

Historical chart of KVP Capital Advisors investment in Cabaletta Bio

Tip: Access up to 7 years of quarterly data

All positions including Cabaletta Bio held by KVP Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cabaletta Bio by KVP Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.1M 505k 2.19

More positions owned by KVP Capital Advisors

Terns Pharmaceuticals (TERN)
Praxis Precision Medicines I Com New (PRAX)
Axsome Therapeutics (AXSM)
Jazz Pharmaceuticals Call Call Option
Aadi Bioscience (WHWK)
Trevi Therapeutics (TRVI)
Insmed Com Par $.01 (INSM)
Protagonist Therapeutics (PTGX)
Disc Medicine (IRON)
Mbx Biosciences (MBX)
Savara (SVRA)
Travere Therapeutics (TVTX)
Edgewise Therapeutics (EWTX)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)

View all positions for KVP Capital Advisors

Top funds holding Cabaletta Bio

Bain Capital Life Sciences Investors
Jennison Associates
Adage Capital Partners GP
T. Rowe Price Investment Management
Cormorant Asset Management
Vanguard Group
Woodline Partners
Heights Capital Management
BlackRock
Superstring Capital Management
Renaissance Technologies
Geode Capital Management
Schonfeld Strategic Advisors
Marshall Wace
Citadel Advisors

View all funds holding Cabaletta Bio